http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023
-
SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023
-
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
-
Shaare Zedek Medical Center Uses SOPHiA GENETICS to Advance Research of Myeloid Disorders
-
Laboratorio Curie Expands Relationship with SOPHiA GENETICS
-
SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM™ Platform
-
CHU Bordeaux is live on SOPHiA GENETICS
-
SOPHiA GENETICS (SOPH) Expands Relationship with Gustave Roussy
-
SOPHiA GENETICS Expands Relationship with Gustave Roussy
-
SOPHiA GENETICS (SOPH) Announces Expanded use of DDM Platform by A.O.U. San Giovanni di Dio Ruggi d'Aragona
-
A.O.U. San Giovanni di Dio Ruggi d'Aragona Expands Usage of SOPHiA GENETICS DDM™ Platform
-
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2023
-
Tulane University School of Medicine Uses SOPHiA GENETICS to Advance Research of Blood Cancers
-
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2023 on August 8, 2023
-
SOPHiA GENETICS Announces Gruppo Centro Servizi Medici (CSM) is Live on the SOPHiA DDM™ Platform
-
Centre Hospitalier de Bastia is Live on SOPHiA GENETICS
-
SOPHiA GENETICS Publishes Results of 2023 Annual General Meeting
-
Ankara Etlik City Hospital is Live on SOPHiA GENETICS Platform
-
NOMAD Genetics is Live on the SOPHiA GENETICS Platform
-
SOPHiA GENETICS Joins CancerX to Help Accelerate Cancer Research
-
SOPHiA GENETICS Announces Nomination of Lila Tretikov to Board of Directors
-
Institute of Oncology Ljubljana Leverages SOPHiA DDM™ Platform for Cancer Research
-
Natural State Laboratories Chooses SOPHiA GENETICS to Help Launch their In-House Hereditary Cancer Testing
-
Dasa Expands Its Capabilities with SOPHiA GENETICS
-
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2023
-
SOPHiA GENETICS Celebrates Swiss Biotech Award
-
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2023 on May 9, 2023
-
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2023 on May 9, 2023
-
The University of Maryland Medical Center Chooses SOPHiA GENETICS Technology
-
Krsnaa Diagnostics is Live on SOPHiA GENETICS
-
Tel Aviv Sourasky Medical Center Chooses SOPHiA DDMTM HRD Solution of SOPHiA GENETICS
-
Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test
-
SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis
-
SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results
-
University of Arkansas for Medical Sciences Will Use SOPHiA GENETICS to Advance Clinical Research for Blood Cancers
-
SOPHiA GENETICS Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
-
SOPHiA GENETICS (SOPH) and Qiagen (QGEN) Partner to Combine Strengths in Next-generation Sequencing
-
SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing
-
Synergy Laboratories Taps SOPHiA GENETICS Technology for New Cancer Profiling Solution
-
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023
-
SOPHiA GENETICS (SOPH) Expands Partnership With AstraZeneca (AZN) to Include Multimodal Approaches for Cancer Drug Development
-
SOPHiA GENETICS Expands Partnership With AstraZeneca to Include Multimodal Approaches for Cancer Drug Development
-
SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies
-
SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference
-
SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022
-
SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022
-
SOPHiA GENETICS to Participate in Upcoming November Investor Conferences
-
SOPHiA GENETICS to Participate in Upcoming November Investor Conferences
-
SOPHiA GENETICS (SOPH) Partners with Microsoft to Accelerate Multimodal Health Data Analysis
-
SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis

